Manila Bulletin
DOH to issue guidelines on AstraZeneca vaccine use -- FDA
The Philippines' Department of Health (DOH) announced the resumption of AstraZeneca COVID-19 vaccinations for individuals under 60 years old.
This decision follows the expert recommendation that the vaccine's benefits outweigh its risks.
The DOH will issue updated guidelines incorporating precautions recommended by the Food and Drug Administration (FDA) due to rare reports of blood clots overseas.
The temporary suspension for the under-60 age group was a precautionary measure, and Vergeire emphasized the very small percentage of the population affected by such adverse events.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Food and Drug Administration (FDA) is expected to release new guidelines this week for the administration of the AstraZeneca COVID-19 vaccine.
Read more →
As of April 13, over 1.2 million doses of COVID-19 vaccines have been administered in the Philippines.
Read more →
The Philippine FDA has granted Emergency Use Authorization (EUA) for Johnson & Johnson's Janssen vaccine and India's Covaxin by Bharat Biotech.
+1
Read more →
The Philippines ranks fourth among Southeast Asian nations in COVID-19 vaccine rollout, according to vaccine czar Secretary Carlito Galvez Jr.
Read more →